Disability weights: Difference between revisions

From Opasnet
Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
(12 intermediate revisions by 3 users not shown)
Line 2: Line 2:
[[Category:Costs and valuations]]
[[Category:Costs and valuations]]
[[Category: CLAIH]]
[[Category: CLAIH]]
{{variable|moderator = Virpi Kollanus
[[Category:Contains R code]]
{{method|moderator = Virpi Kollanus
|respect = 2
|respect = 2
| reference = {{publication
| reference = {{publication
Line 14: Line 15:
}}
}}


'''[[:en:Disability-adjusted life years|DALY]] weights''' describe the weights that are given to different diseases in the calculation of disability-adjusted life years.
'''Disability weights''' describe the weights that are given to different diseases in the calculation of disability-adjusted life years ([[:en:Disability-adjusted life years|DALY]]).


== Scope==
== Question==


[[:en:Disability-adjusted life years|DALY]] weight (also called: disability weight, severity weight) is a number that describes the severity of a disease. It varies from 0 (perfect health) to 1 (death).
What are disability weights for different disases, and how should they be used in calculating burden of disease?


== Definition ==  
==Answer==


=== Causality ===  
This code can be used on this page to calculate YLD (years of life under disease). The code can also be copied to another page in [[Opasnet]]. It runs on [[R]], so it is also possible to copy and use it outside the Opasnet workspace.
List of parents:
 
* No causal parents
<rcode include="page:OpasnetUtils/Summary|name:summary" variables="
name:morbidity.cases|description:How many cases of disease are there? (#)|default:1000|
name:duration|description:What is the duration of disease? (years)|default:1
">
library(OpasnetUtils)
library(xtable)
 
YLD <- new("ovariable",
name = "YLD",
dependencies = data.frame(Name = "morbidity.cases"),
formula = function(dependencies, intermediates = FALSE, ...) {
ComputeDependencies(dependencies, ...)
disability.weight <- EvalOutput(new("ovariable",
name = "disability.weight",
data = tidy(opbase.data("Op_en2307"), objname = "disability.weight") # [[Disability weights]]
))
if(!exists("duration")) {
# duration <- tidy(op_baseGetData("opasnet_base", "Op_enXXXX"), objname = "duration")
duration <- EvalOutput(new("ovariable", # This is a placeholder because actual durations are not known.
name = "duration",
data = data.frame(durationResult = 1)
))
}
 
out <- morbidity.cases * duration * disability.weight
return(out)
}
)
 
#objects.put(YLD)
#cat("Ovariable YLD has been created. Save the run key for further use.\n")
 
morbidity.cases <- new("ovariable",
name = "morbidity.cases",
data = interpret("500-1000") # data.frame(morbidity.casesResult = 1)
)
 
YLD <- EvalOutput(YLD, N = 10)
 
summary(YLD)
 
</rcode>
 
:''NOTE! Old official [http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO disability weights] were used in a [http://en.opasnet.org/en-opwiki/index.php?title=Disability_weights&oldid=26474 previous version] of this page. The current version uses disability weights from Salomon (Salomon et al., Lancet 2012-2013
<ref>Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2129-43. {{doi|10.1016/S0140-6736(12)61680-8}}.</ref>).
 
{{disclink|Formula?}}
 
==Rationale==


=== Data ===  
=== Data ===  


Disability weights are obtained by posing two different Person Trade-Off (PTO) questions to expert panels
Disability weights are obtained by posing two different Person Trade-Off (PTO) questions to expert panels
Question 1 compares life extensions for disabled and healthy people
*Question 1 compares life extensions for disabled and healthy people
Question 2 compares cures for illness with extension of life
*Question 2 compares cures for illness with extension of life


Ideally, these values should be derived from empirical data among representative populations.
Ideally, these values should be derived from empirical data among representative populations.
Line 37: Line 89:
'''Arguments defending this approach include:'''
'''Arguments defending this approach include:'''


- DALY weights are an intrinsically subjective value for which no "true estimate" exists. They should be treated as a normative value, which does not need further uncertainty intervals.
* DALY weights are an intrinsically subjective value for which no "true estimate" exists. They should be treated as a normative value, which does not need further uncertainty intervals.
 
* Uncertainty in very small DALY weights (for less severe effects) affects overall outcomes of DALY calculations much more than uncertainty in large disability weights. This is a "flaw" of the method: if health would be defined as 1 and death as 0 (as is being done with QALYs), the more severe outcomes would have more overall uncertainty. The uncertainty is greatest for the smallest disability weights and narrows as more severe weights are attained (figure 5.16
- Uncertainty in very small DALY weights (for less severe effects) affects overall outcomes of DALY calculations much more than uncertainty in large disability weights. This is a "flaw" of the method: if health would be defined as 1 and death as 0 (as is being done with QALYs), the more severe outcomes would have more overall uncertainty. The uncertainty is greatest for the smallest disability weights and narrows as more severe weights are attained (figure 5.16<ref> Colin D. Mathers, Joshua A. Salomon, Majid Ezzati, Stephen Begg, Stephen Vander Hoorn, and Alan D. Lopez, "Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates." 2006. Global Burden of Disease and Risk Factors,ed. , 399-426. New York: Oxford University Press. DOI: 10.1596/978-0-8213-6262-4/Chpt-5.
<ref> Colin D. Mathers, Joshua A. Salomon, Majid Ezzati, Stephen Begg, Stephen Vander Hoorn, and Alan D. Lopez, "Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates." 2006. Global Burden of Disease and Risk Factors,ed. , 399-426. New York: Oxford University Press. DOI: 10.1596/978-0-8213-6262-4/Chpt-5.
</ref>
</ref>
).This provides a skewed image. In order to avoid this, distributions should not be used. Another solution might be to normalize the weights. {{disclink|normalizing DALY weights?}}
).This provides a skewed image. In order to avoid this, distributions should not be used. Another solution might be to normalize the weights. {{disclink|normalizing DALY weights?}}
[[Image:Severity weights.jpg]]


'''Arguments opposing this approach include:'''
'''Arguments opposing this approach include:'''


- Estimates of DALY weights differ between experts, so this variation should be presented in the overall distribution of these weights.
* Estimates of DALY weights differ between experts, so this variation should be presented in the overall distribution of these weights.


Including uncertainty intervals of disability weights will probably not affect the ranking of overall disease burden estimates very significantly (WHO GBD study). However, it will affect the confidence interval of individual estimates.
Including uncertainty intervals of disability weights will probably not affect the ranking of overall disease burden estimates very significantly (WHO GBD study). However, it will affect the confidence interval of individual estimates.
Line 60: Line 110:
*[http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO data table]
*[http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO data table]


=== Disability weights===


=== Formula ===
Comment: ICD (ICD-10) codes should be added for indexing/OH 19 May 2009
 
{{disclink|Formula?}}
 
*[http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls WHO data table]
 
=== Unit ===
 
dimensionless (between 0 and 1)
 
=== References ===
<references/>


The previous version of disability weights is [http://en.opasnet.org/en-opwiki/index.php?title=Disability_weights&oldid=26474 archived]. The data was from [http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls] (WHO → GBD → Tools → National tools → NATIONAL BURDEN OF DISEASE SUPPLEMENTARY FILES → Disability weights [xls 313kb]).


== Result  ==
'''Disability weights based on IHME (Salomon et al., Lancet 13 Dec, 2012):


Comment: ICD (ICD-10) codes should be added for indexing/OH 19 May 2009
<t2b index="Diagnosis" obs="Weight" unit="fraction">
 
Infectious disease: acute episode, mild|0.005 (0.002-0.011)
The table below is from: http://www.who.int/entity/healthinfo/bodreferencedisabilityweights.xls
Infectious disease: acute episode, moderate|0.053 (0.033-0.081)
(WHO → GBD → Tools → National tools → NATIONAL BURDEN OF DISEASE SUPPLEMENTARY FILES → '''Disability weights [xls 313kb]''').
Infectious disease: acute episode, severe|0.210 (0.139-0.298)
 
Infectious disease: post-acute consequences (fatigue, emotional lability, insomnia)|0.254 (0.170-0.355)
<t2b index="Diagnosis,Age group" locations="0-4,5-14,15-44,45-59,60+" unit="fraction">
Diarrhoea: mild|0.061 (0.036-0.093)
HIVsero-negative cases|0.294|0.294|0.264|0.274|0.274
Diarrhoea: moderate|0.202 (0.133-0.299)
HIVsero-positive cases|0.294|0.294|0.264|0.274|0.274
Diarrhoea: severe|0.281 (0.184-0.399)
Syphilis, Congenital syphilis|0.315|0.315|0.315|0.315|0.315
Epididymo-orchitis|0.097 (0.063-0.137)
Syphilis, Low birth weight|0|0|0|0|0
Herpes zoster|0.061 (0.039-0.094)
Syphilis, Primary|0.015|0.015|0.015|0.014|0.014
HIV: symptomatic, pre-AIDS|0.221 (0.146-0.310)
Syphilis, Secondary|0.048|0.048|0.048|0.048|0.044
HIV/AIDS: receiving antiretroviral treatment|0.053 (0.034-0.079)
Syphilis, Tertiary -- Cardiovascular|0.196|0.196|0.196|0.196|0.196
AIDS: not receiving antiretroviral treatment|0.547 (0.382-0.715)
Syphilis, Tertiary -- Gummas|0.102|0.102|0.102|0.102|0.094
Intestinal nematode infections: symptomatic|0.030 (0.016-0.048)
Syphilis, Tertiary -- Neurologic|0.283|0.283|0.283|0.283|0.283
Lymphatic filariasis: symptomatic|0.110 (0.073-0.157)
Chlamydia, Ophthalmia neonatorum|0.18|0|0|0|0
Ear pain|0.018 (0.009-0.031)
Chlamydia, Low birth weight|0|0|0|0|0
Tuberculosis: without HIV infection|0.331 (0.222- 0.450)
Chlamydia, Corneal scar -- Blindness|0.493|0.491|0.488|0.488|0.488
Tuberculosis: with HIV infection|0.399 (0.267-0.547)
Chlamydia, Corneal scar -- Low vision|0.223|0.245|0.245|0.245|0.245
Cancer: diagnosis and primary therapy|0.294 (0.199-0.411)
Chlamydia, Cervicitis|0.049|0.049|0.049|0.049|0.049
Cancer: metastatic|0.484 (0.330-0.643)
Chlamydia, Neonatal pneumonia|0.28|0.28|0.276|0.276|0.28
Mastectomy|0.038 (0.022-0.059)
Chlamydia, Pelvic inflammatory disease|0.169|0.169|0.169|0.169|0.169
Stoma|0.086 (0.055-0.131)
Chlamydia, Ectopic pregnancy|0|0.549|0.549|0.549|0
Terminal phase: with medication (for cancers, end-stage kidney or liver disease)|0.508 (0.348-0.670)
Chlamydia, Tubo-ovarian abscess|0|0.549|0.549|0.549|0
Terminal phase: without medication (for cancers, end-stage kidney or liver disease)|0.519 (0.356-0.683)
Chlamydia, Chronic pelvic pain|0.122|0.122|0.122|0.122|0.122
Acute myocardial infarction: days 1-2|0.422 (0.284-0.566)
Chlamydia, Infertility|0.18|0.18|0.18|0.18|0.18
Acute myocardial infarction: days 3-28|0.056 (0.035-0.082)
Chlamydia, Symptomatic urethritis|0.067|0.067|0.067|0.067|0.067
Angina pectoris: mild|0.037 (0.022-0.058)
Chlamydia, Epididymitis|0.167|0.167|0.167|0.167|0.167
Angina pectoris: moderate|0.066 (0.043-0.095)
Chlamydia, Stricture|0.151|0.151|0.151|0.151|0.151
Angina pectoris: severe|0.167 (0.109-0.234)
Gonorrhoea, Ophthalmia neonatorum|0.18|0|0|0|0
Cardiac conduction disorders and cardiac dysrhythmias|0.145 (0.097-0.205)
Gonorrhoea, Low birth weight|0|0|0|0|0
Claudication|0.016 (0.008-0.028)
Gonorrhoea, Corneal scar -- Blindness|0.6|0|0|0|0
Heart failure: mild|0.037 (0.021-0.058)
Gonorrhoea, Corneal scar -- Low vision|0.223|0.245|0.245|0.245|0.245
Heart failure: moderate|0.070 (0.044-0.102)
Gonorrhoea, Cervicitis|0.049|0.049|0.049|0.049|0.049
Heart failure: severe|0.186 (0.128-0.261)
Gonorrhoea, Pelvic inflammatory disease|0.169|0.169|0.169|0.169|0.169
Stroke: long-term consequences, mild|0.021 (0.011-0.037)
Gonorrhoea, Ectopic pregnancy|0|0.549|0.549|0.549|0
Stroke: long-term consequences, moderate|0.076 (0.050-0.110)
Gonorrhoea, Tubo-ovarian abscess|0|0.549|0.549|0.549|0
Stroke: long-term consequences, moderate plus cognition problems|0.312 (0.211-0.433)
Gonorrhoea, Chronic pelvic pain|0.122|0.122|0.122|0.122|0.122
Stroke: long-term consequences, severe|0.539 (0.363-0.705)
Gonorrhoea, Infertility|0.18|0.18|0.18|0.18|0.18
Stroke: long-term consequences, severe plus cognition problems|0.567 (0.394-0.738)
Gonorrhoea, Symptomatic urethritis|0.067|0.067|0.067|0.067|0.067
Diabetic foot|0.023 (0.012-0.039)
Gonorrhoea, Epididymitis|0.167|0.167|0.167|0.167|0.167
Diabetic neuropathy|0.099 (0.066-0.145)
Gonorrhoea, Stricture|0.151|0.151|0.151|0.151|0.151
Chronic kidney disease (stage IV)|0.105 (0.069-0.154)
HIV, Cases|0.123|0.123|0.136|0.136|0.136
End-stage renal disease: with kidney transplant|0.027 (0.015-0.043)
HIV, AIDS|0.505|0.505|0.505|0.505|0.505
End-stage renal disease: on dialysis|0.573 (0.397-0.749)
HIV, Diarrhoeal diseases -- Episodes|0.119|0.094|0.086|0.086|0.088
Decompensated cirrhosis of the liver|0.194 (0.127-0.273)
Pertussis, Episodes|0|0|0|0|0
Gastric bleeding|0.323 (0.214-0.461)
Pertussis, Mental retardation|0.394|0.42|0.451|0.466|0.468
Crohn's disease or ulcerative colitis|0.225 (0.152-0.314)
Pertussis, Poliomyelitis -- Lameness|0.369|0.369|0.369|0.369|0.369
Benign prostatic hypertrophy: symptomatic|0.070 (0.046-0.102)
Diphtheria, Episodes|0.231|0.23|0.23|0.23|0.23
Urinary incontinence|0.142 (0.094-0.204)
Diphtheria, Neurological complications|0.078|0.078|0.078|0.078|0.078
Impotence|0.019 (0.010-0.034)
Diphtheria, Myocarditis|0.323|0.323|0.323|0.323|0.323
Infertility: primary|0.011 (0.005-0.021)
Diphtheria, Measles -- Episodes|0.152|0.152|0.152|0.152|0.152
Infertility: secondary|0.006 (0.002-0.013)
Diphtheria, Tetanus -- Episodes|0.64|0.64|0.61|0.604|0.612
Asthma: controlled|0.009 (0.004-0.018)
Bacterial meningitis, meningococcaemia, Streptococcus pneumoniae -- Episodes|0.616|0.616|0.613|0.613|0.613
Asthma: partially controlled|0.027 (0.015-0.045)
Bacterial meningitis, meningococcaemia, Haemophilus influenzae -- Episodes|0.616|0.616|0.613|0.613|0.613
Asthma: uncontrolled|0.132 (0.087-0.190)
Bacterial meningitis, meningococcaemia, Neisseria meningitidis -- Episodes|0.616|0.616|0.613|0.613|0.613
COPD and other chronic respiratory diseases: mild|0.015 (0.007-0.028)
Meningococcaemia without meningitis --, Episodes|0.152|0.152|0.152|0.152|0.152
COPD and other chronic respiratory diseases: moderate|0.192 (0.129-0.271)
Meningococcaemia without meningitis --, Deafness|0.175|0.169|0.168|0.168|0.168
COPD and other chronic respiratory diseases: severe|0.383 (0.259-0.528)
Meningococcaemia without meningitis --, Seizure disorder|0.041|0.065|0.065|0.065|0.065
Dementia: mild|0.082 (0.055-0.117)
Meningococcaemia without meningitis --, Motor deficit|0.334|0.334|0.334|0.337|0.39
Dementia: moderate|0.346 (0.233-0.475)
Meningococcaemia without meningitis --, Mental retardation|0.394|0.42|0.451|0.466|0.468
Dementia: severe|0.438 (0.299-0.584)
Meningococcaemia without meningitis --, Hepatitis B and hepatitis C -- Episodes|0.17|0.181|0.209|0.212|0.212
Headache: migraine|0.433 (0.287-0.593)
Malaria, Episodes|0.211|0.195|0.172|0.172|0.172
Headache: tension-type|0.040 (0.025-0.062)
Malaria, Anaemia|0.012|0.012|0.012|0.013|0.012
Multiple sclerosis: mild|0.198 (0.137-0.278)
Malaria, Neurological sequelae|0.436|0.435|0.435|0.435|0.435
Multiple sclerosis: moderate|0.445 (0.303-0.593)
Malaria, Trypanosomiasis -- Episodes|0.35|0.35|0.35|0.35|0.35
Multiple sclerosis: severe|0.707 (0.522-0.857)
Chagas disease, Infection|0|0|0|0|0
Epilepsy: treated, seizure free|0.072 (0.047-0.106)
Cardiomyopathy without congestive heart failure|0.062|0.062|0.062|0.062|0.062
Epilepsy: treated, with recent seizures|0.319 (0.211-0.445)
Cardiomyopathy with congestive heart failure|0.171|0.171|0.171|0.171|0.171
Epilepsy: untreated|0.420 (0.279-0.572)
Megaviscera|0.24|0.24|0.24|0.24|0.24
Epilepsy: severe|0.657 (0.464-0.827)
Schistosomiasis -- Infection|0.005|0.005|0.006|0.006|0.006
Parkinson's disease: mild|0.011 (0.005-0.021)
Leishmaniasis, Visceral|0.243|0.243|0.243|0.243|0.243
Parkinson's disease: moderate|0.263 (0.179-0.360)
Leishmaniasis, Cutaneous|0.023|0.023|0.023|0.023|0.023
Parkinson's disease: severe|0.549 (0.383-0.711)
Lymphatic filariasis, Hydrocele >15 cm|0.066|0.07|0.075|0.075|0.075
Alcohol use disorder: mild|0.259 (0.176-0.359)
Lymphatic filariasis, Bancroftian lymphoedema|0.067|0.08|0.113|0.128|0.119
Alcohol use disorder: moderate|0.388 (0.262-0.529)
Lymphatic filariasis, Brugian lymphoedema|0.064|0.08|0.113|0.128|0.119
Alcohol use disorder: severe|0.549 (0.384-0.708)
Onchocerciasis, Blindness|0.493|0.491|0.488|0.488|0.488
Fetal alcohol syndrome: mild|0.017 (0.008-0.032)
Onchocerciasis, Itching|0.068|0.068|0.068|0.068|0.068
Fetal alcohol syndrome: moderate|0.057 (0.036-0.087)
Onchocerciasis, Low vision|0.223|0.245|0.245|0.245|0.245
Fetal alcohol syndrome: severe|0.177 (0.117-0.255)
Leprosy, Cases|0|0|0|0|0
Cannabis dependence|0.329 (0.223-0.455)
Leprosy, Disabling leprosy|0.153|0.153|0.153|0.153|0.153
Amphetamine dependence|0.353 (0.215-0.525)
Dengue, Dengue haemorrhagic fever|0.211|0.195|0.172|0.172|0.172
Cocaine dependence|0.376 (0.235-0.553)
Japanese encephalitis, Episodes|0.616|0.616|0.613|0.613|0.613
Heroin and other opioid dependence|0.641 (0.459-0.803)
Japanese encephalitis, Cognitive impairment|0.394|0.42|0.451|0.466|0.468
Anxiety disorders: mild|0.030 (0.017-0.048)
Japanese encephalitis, Neurological sequelae|0.334|0.334|0.334|0.337|0.39
Anxiety disorders: moderate|0.149 (0.101-0.210)
Trachoma, Blindness|0.493|0.491|0.488|0.488|0.488
Anxiety disorders: severe|0.523 (0.365-0.684)
Trachoma, Low Vision|0.223|0.245|0.245|0.245|0.245
Major depressive disorder: mild episode|0.159 (0.107-0.223)
Ascariasis, High intensity infection|0|0|0|0|0
Major depressive disorder: moderate episode|0.406 (0.276-0.551)
Ascariasis, Cotemporaneous cognitive deficit|0.006|0.006|0.006|0.006|0.006
Major depressive disorder: severe episode|0.655 (0.469-0.816)
Ascariasis, Cognitive impairment|0.463|0.463|0.463|0.463|0.463
Bipolar disorder: manic episode|0.480 (0.323-0.642)
Ascariasis, Intestinal obstruction|0.024|0.024|0.024|0.024|0.024
Bipolar disorder: residual state|0.035 (0.021-0.055)
Trichuriasis, High intensity infection|0|0|0|0|0
Schizophrenia: acute state|0.756 (0.571-0.894)
Trichuriasis, Cotemporaneous cognitive deficit|0.006|0.006|0.006|0.006|0.006
Schizophrenia: residual state|0.576 (0.399-0.756)
Trichuriasis, Massive dysentery syndrome|0.138|0.116|0.114|0.114|0.129
Anorexia nervosa|0.223 (0.151-0.313)
Trichuriasis, Cognitive impairment|0.024|0.024|0.024|0.024|0.024
Bulimia nervosa|0.223 (0.150-0.310)
Ancylostomiasis and necatoriasis, High intensity infection|0|0|0|0|0
Attention-deficit hyperactivity disorder|0.049 (0.031-0.074)
Ancylostomiasis and necatoriasis, Anaemia|0.024|0.024|0.024|0.024|0.024
Conduct disorder|0.236 (0.154-0.337)
Ancylostomiasis and necatoriasis, Cognitive impairment|0.024|0.024|0.024|0.024|0.024
Asperger's syndrome|0.110 (0.073-0.157)
Lower respiratory infections, Episodes|0.28|0.28|0.276|0.276|0.28
Autism|0.259 (0.177-0.362)
Lower respiratory infections, Chronic sequelae|0.099|0.099|0.099|0.099|0.099
Intellectual disability: mild|0.031 (0.018-0.049)
Upper respiratory infections, Episodes|0|0|0|0|0
Intellectual disability: moderate|0.080 (0.053-0.114)
Upper respiratory infections, Pharyngitis|0.07|0.07|0.07|0.07|0.07
Intellectual disability: severe|0.126 (0.085-0.176)
Otitis media, Episodes|0.023|0.023|0.023|0.023|0.023
Intellectual disability: profound|0.157 (0.107-0.221)
Otitis media, Deafness|0.175|0.169|0.168|0.168|0.168
Hearing loss: mild|0.005 (0.002-0.012)
Maternal haemorrhage, Episodes|0|0|0|0|0
Hearing loss: moderate|0.023 (0.013-0.038)
Maternal haemorrhage, Sheehan syndrome|0.065|0.065|0.065|0.065|0.065
Hearing loss: severe|0.032 (0.018-0.051)
Maternal haemorrhage, Severe anaemia|0.087|0.087|0.093|0.09|0.087
Hearing loss: profound|0.031 (0.018-0.049)
Maternal sepsis, Episodes|0|0|0|0|0
Hearing loss: complete|0.033 (0.020-0.052)
Maternal sepsis, Infertility|0|0|0.18|0|0
Hearing loss: mild, with ringing|0.038 (0.024-0.058)
Hypertensive disorders of pregnancy, Episodes|0|0|0|0|0
Hearing loss: moderate, with ringing|0.058 (0.037-0.085)
Hypertensive disorders of pregnancy, Neurological sequelae|0.388|0.388|0.388|0.397|0.468
Hearing loss: severe, with ringing|0.065 (0.041-0.094)
Obstructed labour, Episodes|0|0|0|0|0
Hearing loss: profound, with ringing|0.088 (0.058-0.127)
Obstructed labour, Stress incontinence|0.025|0.025|0.025|0.025|0.033
Hearing loss: complete, with ringing|0.092 (0.061-0.134)
Obstructed labour, Rectovaginal fistula|0|0|0.43|0|0
Distance vision: mild impairment|0.004 (0.001-0.010)
Abortion, Episodes|0|0|0|0|0
Distance vision: moderate impairment|0.033 (0.020-0.052)
Abortion, Infertility|0|0|0.18|0|0
Distance vision: severe impairment|0.191 (0.129-0.269)
Abortion, Low birth weight -- All sequelae|0.256|0.256|0.256|0.256|0.256
Distance vision blindness|0.195 (0.132-0.272)
Birth asphyxia and birth trauma -- All sequelae|0.334|0.334|0.334|0.334|0.334
Near vision impairment|0.013 (0.006-0.024)
Protein-energy malnutrition, Wasting|0.053|0|0|0|0
Low back pain: acute, without leg pain|0.269 (0.184-0.373)
Protein-energy malnutrition, Stunting|0.002|0|0|0|0
Low back pain: acute, with leg pain|0.322 (0.219-0.447)
Protein-energy malnutrition, Developmental disability|0.024|0.024|0.024|0.024|0.024
Low back pain: chronic, without leg pain|0.366 (0.248-0.499)
Iodine deficiency, Goitre -- grade 0|0|0|0|0|0
Low back pain: chronic, with leg pain|0.374 (0.252-0.506)
Iodine deficiency, Goitre -- grade 1|0.001|0.001|0.001|0.001|0.001
Neck pain: acute, mild|0.040 (0.023-0.064)
Iodine deficiency, Goitre -- grade 2|0.025|0.025|0.025|0.025|0.025
Neck pain: acute, severe|0.221 (0.150-0.305)
Iodine deficiency, Mild developmental disability|0.006|0.006|0.006|0.006|0.006
Neck pain: chronic, mild|0.101 (0.067-0.149)
Iodine deficiency, Cretinoidism|0.255|0.255|0.255|0.255|0.255
Neck pain: chronic, severe|0.286 (0.197-0.398)
Iodine deficiency, Cretinism|0.804|0.804|0.804|0.804|0.804
Musculoskeletal problems: legs, mild|0.023 (0.013-0.039)
Vitamin A deficiency, Xerophthalmia|0|0|0|0|0
Musculoskeletal problems: legs, moderate|0.079 (0.053-0.115)
Vitamin A deficiency, Corneal scar|0.274|0.282|0.282|0.282|0.282
Musculoskeletal problems: legs, severe|0.171 (0.117-0.240)
Iron-deficiency anaemia, Mild|0|0|0|0|0
Musculoskeletal problems: arms, mild|0.024 (0.014-0.041)
Iron-deficiency anaemia, Moderate|0.011|0.011|0.011|0.012|0.012
Musculoskeletal problems: arms, moderate|0.114 (0.077-0.159)
Iron-deficiency anaemia, Severe|0.087|0.087|0.093|0.09|0.087
Musculoskeletal problems: generalised, moderate|0.292 (0.197-0.410)
Iron-deficiency anaemia, Very severe|0.241|0.244|0.255|0.252|0.252
Musculoskeletal problems: generalised, severe|0.606 (0.421-0.771)
Iron-deficiency anaemia, Cognitive impairment|0.024|0.024|0.024|0.024|0.024
Gout: acute|0.293 (0.198-0.404)
Cancers -- Preterminal, Mouth and oropharynx|0.09|0.09|0.09|0.09|0.09
Amputation of finger(s), excluding thumb: long term, with treatment|0.030 (0.018-0.048)
Cancers -- Preterminal, Oesophagus|0.217|0.217|0.217|0.217|0.217
Amputation of thumb: long term|0.013 (0.006-0.025)
Cancers -- Preterminal, Stomach|0.217|0.217|0.217|0.217|0.217
Amputation of one arm: long term, with or without treatment|0.130 (0.088-0.185)
Cancers -- Preterminal, Colon and rectum|0.217|0.217|0.217|0.217|0.217
Amputation of both arms: long term, with treatment|0.044 (0.028-0.067)
Cancers -- Preterminal, Liver|0.239|0.239|0.239|0.239|0.239
Amputation of both arms: long term, without treatment|0.359 (0.242-0.497)
Cancers -- Preterminal, Pancreas|0.237|0.237|0.237|0.237|0.237
Amputation of toe|0.008 (0.003-0.017)
Cancers -- Preterminal, Trachea, bronchus and lung|0.146|0.146|0.146|0.146|0.146
Amputation of one leg: long term, withtreatment|0.021 (0.011-0.035)
Cancers -- Preterminal, Melanoma and other skin|0.045|0.045|0.045|0.045|0.045
Amputation of one leg: long term, without treatment|0.164 (0.111-0.229)
Cancers -- Preterminal, Breast|0.086|0.086|0.086|0.086|0.086
Amputation of both legs: long term, with treatment|0.051 (0.032-0.076)
Cancers -- Preterminal, Cervix uteri|0.075|0.075|0.075|0.075|0.075
Amputation of both legs: long term, without treatment|0.494 (0.341-0.654)
Cancers -- Preterminal, Corpus uteri|0.099|0.104|0.104|0.096|0.079
Burns of <20% total surface area without lower airway burns: short term, with or without treatment|0.096 (0.062-0.140)
Cancers -- Preterminal, Ovary|0.097|0.097|0.097|0.084|0.059
Burns of <20% total surface area or <10% total surface area if head or neck, or hands or wrist involved: long term, with or without treatment|0.018 (0.010-0.032)
Cancers -- Preterminal, Prostate|0.134|0.134|0.134|0.134|0.134
Burns of ≥20% total surface area: short term, with or without treatment|0.333 (0.220-0.472)
Cancers -- Preterminal, Bladder|0.087|0.087|0.087|0.087|0.085
Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, with treatment|0.127 (0.086-0.183)
Cancers -- Preterminal, Lymphomas and multiple myeloma|0.057|0.057|0.057|0.057|0.057
Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, without treatment|0.438 (0.298-0.588)
Cancers -- Preterminal, Leukaemia|0.083|0.083|0.093|0.097|0.097
Lower airway burns: with or without treatment|0.373 (0.248-0.521)
Cancers -- terminal,|0.809|0.809|0.809|0.809|0.809
Crush injury: short or long term, with or without treatment|0.145 (0.093-0.211)
Diabetes mellitus, Cases|0.033|0.033|0.033|0.033|0.033
Dislocation of hip: long term, with or without treatment|0.017 (0.008-0.030)
Diabetes mellitus, Diabetic foot|0.129|0.129|0.129|0.129|0.129
Dislocation of knee: long term, with or without treatment|0.129 (0.087-0.178)
Diabetes mellitus, Neuropathy|0.064|0.064|0.064|0.064|0.064
Dislocation of shoulder: long term, with or without treatment|0.080 (0.053-0.116)
Diabetes mellitus, Retinopathy -- Blindness|0.493|0.491|0.488|0.488|0.488
Other injuries of muscle and tendon (includes sprains, strains, and dislocations other than shoulder, knee, or hip)|0.009 (0.004-0.018)
Diabetes mellitus, Amputation|0.068|0.068|0.068|0.068|0.068
Drowning and non-fatal submersion: short or long term, with or without treatment|0.288 (0.191-0.403)
Diabetes mellitus, Unipolar major depression -- episodes|0.302|0.302|0.302|0.302|0.302
Fracture of clavicle, scapula, or humerus: short or long term, with or without treatment|0.053 (0.033-0.080)
Diabetes mellitus, Bipolar disorder -- Cases|0.383|0.383|0.383|0.383|0.383
Fracture of face bone: short or long term, with or without treatment|0.173 (0.111- 0.257)
Diabetes mellitus, Schizophrenia -- Cases|0.351|0.351|0.351|0.351|0.351
Fracture of foot bones: short term, with or without treatment|0.033 (0.019-0.053)
Diabetes mellitus, Epilepsy -- Cases|0.041|0.065|0.065|0.065|0.065
Fracture of foot bones: long term, without treatment|0.033 (0.019-0.052)
Diabetes mellitus, Alcohol use --|0.18|0.18|0.18|0.18|0.18
Fracture of hand: short term, with or without treatment|0.025 (0.013-0.043)
Diabetes mellitus, Alcohol dependence syndrome|0.18|0.18|0.18|0.18|0.18
Fracture of hand: long term, without treatment|0.016 (0.008-0.028)
Diabetes mellitus, Dementia -- Cases|0.627|0.627|0.627|0.645|0.667
Fracture of neck of femur: short term, with or without treatment|0.308 (0.205-0.439)
Diabetes mellitus, Parkinson disease -- Cases|0.316|0.316|0.316|0.316|0.332
Fracture of neck of femur: long term, with treatment|0.072 (0.047-0.105)
Diabetes mellitus, Multiple sclerosis -- Cases|0.41|0.41|0.41|0.42|0.437
Fracture of neck of femur: long term, without treatment|0.388 (0.261-0.532)
Drug use --Dysfunctional and harmful drug use|0.252|0.252|0.25|0.25|0.25
Fracture other than neck of femur: short term, with or without treatment|0.192 (0.121-0.280)
Drug use --Post-traumatic stress disorder -- Cases|0.105|0.105|0.108|0.108|0.108
Fracture other than neck of femur: long term, without treatment|0.053 (0.035-0.079)
Obsessive-compulsive disorders --, Cases|0.08|0.08|0.08|0.08|0.08
Fracture of patella, tibia or fibula, or ankle: short term, with or without treatment|0.087 (0.055-0.127)
Obsessive-compulsive disorders --, Panic disorder -- Cases|0.091|0.091|0.091|0.091|0.091
Fracture of patella, tibia or fibula, or ankle: long term, with or without treatment|0.070 (0.047-0.102)
Obsessive-compulsive disorders --, Glaucoma -- Blindness|0.6|0.6|0.6|0.6|0.6
Fracture of pelvis: short term|0.390 (0.257-0.545)
Obsessive-compulsive disorders --, Cataracts -- Blindness|0.493|0.491|0.488|0.488|0.488
Fracture of pelvis: long term|0.194 (0.132-0.272)
Rheumatic heart disease --, Congestive heart failure|0.171|0.171|0.171|0.171|0.171
Fracture of radius or ulna: short term, with or without treatment|0.065 (0.040-0.101)
Ischaemic heart disease, Acute myocardial infarction|0.395|0.395|0.395|0.395|0.395
Fracture of radius or ulna: long term, without treatment|0.050 (0.032-0.075)
Ischaemic heart disease, Angina pectoris|0.095|0.095|0.095|0.095|0.095
Fracture of skull: short or long term, with or without treatment|0.073 (0.046-0.109)
Ischaemic heart disease, Congestive heart failure|0.171|0.171|0.171|0.171|0.171
Fracture of sternum or fracture of one or two ribs: short term, with or without treatment|0.150 (0.098-0.215)
Cerebrovascular disease --, First-ever stroke|0.224|0.224|0.224|0.224|0.258
Fracture of vertebral column: short or long term, with or without treatment|0.132 (0.085-0.195)
Inflammatory heart diseases, Myocarditis|0.171|0.171|0.171|0.171|0.171
Fractures: treated, long term|0.003 (0.001-0.008)
Inflammatory heart diseases, Pericarditis|0.171|0.171|0.171|0.171|0.171
Injured nerves: short term|0.065 (0.040-0.096)
Inflammatory heart diseases, Endocarditis|0.171|0.171|0.171|0.171|0.171
Injured nerves: long term|0.136 (0.092-0.189)
Inflammatory heart diseases, Cardiomyopathy|0.171|0.171|0.171|0.171|0.171
Injury to eyes: short term|0.079 (0.050-0.118)
Inflammatory heart diseases, COPD -- Symptomatic cases|0.388|0.388|0.388|0.388|0.388
Severe traumatic brain injury: short term, with or without treatment|0.235 (0.156-0.331)
Inflammatory heart diseases, Asthma -- Cases|0.059|0.059|0.059|0.059|0.059
Traumatic brain injury: long-term consequences, minor, with or without treatment|0.106 (0.072-0.147)
Inflammatory heart diseases, Peptic ulcer -- Cases|0.003|0.003|0.003|0.003|0.003
Traumatic brain injury: long-term consequences, moderate, with or without treatment|0.224 (0.153-0.314)
Cirrhosis of the liver --, Symptomatic cases|0.33|0.33|0.33|0.33|0.33
Traumatic brain injury: long-term consequences, severe, with or without treatment|0.625 (0.444-0.789)
Cirrhosis of the liver --, Appendicitis -- Episodes|0.463|0.463|0.463|0.463|0.463
Open wound: short term, with or without treatment|0.005 (0.002-0.013)
Nephritis and nephrosis, Acute glomerulonephritis|0.107|0.107|0.107|0.096|0.096
Poisoning: short term, with or without treatment|0.171 (0.116-0.239)
Nephritis and nephrosis, End-stage renal disease|0.107|0.107|0.107|0.096|0.096
Severe chest injury: long term, with or without treatment|0.056 (0.036-0.082)
Benign prostatic hypertrophy --, Symptomatic cases|0.038|0.038|0.038|0.038|0.038
Severe chest injury: short term, with or without treatment|0.352 (0.229-0.484)
Benign prostatic hypertrophy --, Rheumatoid arthritis -- Cases|0.174|0.174|0.174|0.174|0.174
Spinal cord lesion below neck: treated|0.047 (0.029-0.072)
Osteoarthritis, Hip|0.108|0.108|0.108|0.108|0.108
Spinal cord lesion below neck: untreated|0.440 (0.290-0.588)
Osteoarthritis, Knee|0.108|0.108|0.108|0.108|0.108
Spinal cord lesion at neck: treated|0.369 (0.243-0.513)
Congenital anomalies, Abdominal wall defect -- Cases|0.85|0|0|0|0
Spinal cord lesion at neck: untreated|0.673 (0.475-0.837)
Congenital anomalies, Anencephaly -- Cases|0.85|0|0|0|0
Abdominopelvic problem: mild|0.012 (0.005-0.023)
Congenital anomalies, Anorectal atresia -- Cases|0.85|0|0|0|0
Abdominopelvic problem: moderate|0.123 (0.083-0.176)
Congenital anomalies, Cleft lip -- Cases|0.016|0|0|0|0
Abdominopelvic problem: severe|0.326 (0.219-0.451)
Congenital anomalies, Cleft palate -- Cases|0.015|0|0|0|0
Anaemia: mild|0.005 (0.002-0.011)
Congenital anomalies, Oesophageal atresia -- Cases|0.85|0|0|0|0
Anaemia: moderate|0.058 (0.038-0.086)
Congenital anomalies, Renal agenesis -- Cases|0.85|0|0|0|0
Anaemia: severe|0.164 (0.112-0.228)
Congenital anomalies, Down syndrome -- Cases|0.593|0.593|0.593|0.593|0.593
Periodontitis|0.008 (0.003-0.017)
Congenital anomalies, Congenital heart anomalies -- Cases|0.323|0.323|0.323|0.323|0.323
Dental caries: symptomatic|0.012 (0.005-0.023)
Congenital anomalies, Spina bifida -- Cases|0.593|0.593|0.593|0.593|0.593
Severe tooth loss|0.072 (0.048-0.103)
Congenital anomalies, Dental caries -- Episodes|0.081|0.081|0.081|0.081|0.081
Disfigurement: level 1|0.013 (0.006-0.025)
Congenital anomalies, Periodontal disease -- Episodes|0.001|0.001|0.001|0.001|0.001
Disfigurement: level 2|0.072 (0.048-0.103)
Congenital anomalies, Edentulism -- Cases|0.001|0.001|0.001|0.001|0.001
Disfigurement: level 3|0.398 (0.271-0.543)
Drownings, Episodes|0|0|0|0|0
Disfigurement: level 1 with itch or pain|0.029 (0.016-0.048)
Drownings, Quadriplegia|0.005|0.005|0.005|0.005|0.005
Disfigurement: level 2, with itch or pain|0.187 (0.125-0.264)
Drownings, Poisoning -- Episodes|0.611|0.611|0.607|0.607|0.607
Disfigurement: level 3, with itch or pain|0.562 (0.394-0.725)
Fractures, Skull -- Short term|0.431|0.431|0.431|0.431|0.431
Generic uncomplicated disease: worry and daily medication|0.031 (0.017-0.050)
Fractures, Skull -- Long term|0.35|0.35|0.35|0.35|0.404
Generic uncomplicated disease: anxiety about diagnosis|0.054 (0.033-0.082)
Fractures, Face bones|0.223|0.223|0.223|0.223|0.223
Iodine-deficiency goitre|0.200 (0.134-0.283)
Fractures, Vertebral column|0.266|0.266|0.266|0.266|0.266
Kwashiorkor|0.055 (0.033-0.085)
Fractures, Injured spinal cord|0.725|0.725|0.725|0.725|0.725
Severe wasting|0.127 (0.081-0.183)
Fractures, Rib or sternum|0.199|0.199|0.199|0.199|0.199
Speech problems|0.054 (0.034-0.081)
Fractures, Pelvis|0.247|0.247|0.247|0.247|0.247
Motor impairment: mild|0.012 (0.005-0.022)
Fractures, Clavicle, scapula, or humerus|0.153|0.153|0.137|0.137|0.137
Motor impairment: moderate|0.076 (0.050-0.109)
Fractures, Radius or ulna|0.18|0.18|0.18|0.18|0.18
Motor impairment: severe|0.377 (0.251-0.518)
Fractures, Hand bones|0.1|0.1|0.1|0.1|0.1
Motor plus cognitive impairments: mild|0.054 (0.033-0.084)
Fractures, Femur -- Short term|0.372|0.372|0.372|0.372|0.372
Motor plus cognitive impairments: moderate|0.221 (0.141-0.314)
Fractures, Femur -- Long term|0.272|0.272|0.272|0.272|0.272
Motor plus cognitive impairments: severe|0.425 (0.286-0.587)
Fractures, Patella, tibia, or fibula|0.271|0.271|0.271|0.271|0.271
Rectovaginal fistula|0.492 (0.330-0.660)
Fractures, Ankle|0.196|0.196|0.196|0.196|0.196
Vesicovaginal fistula|0.338 (0.228-0.467)
Fractures, Foot bones|0.077|0.077|0.077|0.077|0.077
Fractures, Dislocated shoulder, elbow, or hip|0.074|0.074|0.074|0.074|0.074
Fractures, Sprains|0.064|0.064|0.064|0.064|0.064
Intracranial injury, Short term|0.359|0.359|0.359|0.359|0.359
Intracranial injury, Long term|0.359|0.359|0.359|0.359|0.359
Intracranial injury, Internal injuries|0.208|0.208|0.208|0.208|0.208
Intracranial injury, Open wound|0.108|0.108|0.108|0.108|0.108
Intracranial injury, Injury to eyes|0.301|0.3|0.299|0.299|0.299
Amputations, Thumb|0.165|0.165|0.165|0.165|0.165
Amputations, Finger|0.102|0.102|0.102|0.102|0.102
Amputations, Arm|0.102|0.102|0.102|0.102|0.102
Amputations, Toe|0.064|0.064|0.064|0.064|0.064
Amputations, Foot|0.3|0.3|0.3|0.3|0.3
Amputations, Leg|0.3|0.3|0.3|0.3|0.3
Amputations, Crushing|0.218|0.218|0.218|0.218|0.218
Burns, <20% -- Short term|0.158|0.158|0.158|0.158|0.158
Burns, <20% -- Long term|0.011|0.011|0.011|0.011|0.011
Burns, >20% and <60% -- Short term|0.441|0.441|0.441|0.441|0.441
Burns, >20% and <60% -- Long term|0.255|0.255|0.255|0.255|0.255
Burns, >60% -- Short term|0.441|0.441|0.441|0.441|0.441
Burns, >60% -- Long term|0.255|0.255|0.255|0.255|0.255
Burns, Injured nerves|0.064|0.064|0.064|0.064|0.064
</t2b>
</t2b>


===Old table===
== See also ==
 
{| {{prettytable}}
|+ '''Annex Table 3. Age-specific disability weights for untreated and treated forms of sequelae included in the Global Burden of Disease Study.
|-
|
! colspan="5" | Untreated form
|
! colspan="5" | Treated form
|-
! Diagnosis
! colspan="5" | Age group (years)
|
! colspan="5" | Age group (years)
|-
| Sequela
| 0-4
| 5-14
| 15-44
| 45-59
| 60+
|
| 0-4
| 5-14
| 15-44
| 45-59
| 60+
|-
| Tuberculosis
|
|
|
|
|
|
|
|
|
|
|
|-
| HIV sero-negative cases
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|-
| HIV sero-positive cases
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|
| 0.294
| 0.294
| 0.264
| 0.274
| 0.274
|-
| Syphilis
|
|
|
|
|
|
|
|
|
|
|
|-
| Congenital syphilis
| 0.315
| 0.315
| 0.315
| 0.315
| 0.315
|
| 0.315
| 0.315
| 0.315
| 0.315
| 0.315
|-
| Low birth weight
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Primary
| 0.015
| 0.015
| 0.015
| 0.014
| 0.014
|
| 0.015
| 0.015
| 0.015
| 0.014
| 0.014
|-
| Secondary
| 0.048
| 0.048
| 0.048
| 0.048
| 0.044
|
| 0.048
| 0.048
| 0.048
| 0.048
| 0.044
|-
| Tertiary -- Cardiovascular
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|-
| Tertiary -- Gummas
| 0.102
| 0.102
| 0.102
| 0.102
| 0.094
|
| 0.102
| 0.102
| 0.102
| 0.102
| 0.094
|-
| Tertiary -- Neurologic
| 0.283
| 0.283
| 0.283
| 0.283
| 0.283
|
| 0.283
| 0.283
| 0.283
| 0.283
| 0.283
|-
| Chlamydia
|
|
|
|
|
|
|
|
|
|
|
|-
| Ophthalmia neonatorum
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Low birth weight
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Corneal scar -- Low vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Cervicitis
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|-
| Neonatal pneumonia
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|-
| Pelvic inflammatory disease
| 0.420
| 0.420
| 0.420
| 0.420
| 0.420
|
| 0.169
| 0.169
| 0.169
| 0.169
| 0.169
|-
| Ectopic pregnancy
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Tubo-ovarian abscess
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Chronic pelvic pain
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|-
| Infertility
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Symptomatic urethritis
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|-
| Epididymitis
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|-
| Stricture
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|-
| Gonorrhoea
|
|
|
|
|
|
|
|
|
|
|
|-
| Ophthalmia neonatorum
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.180
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Low birth weight
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar -- Blindness
| 0.600
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.600
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar -- Low vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Cervicitis
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|
| 0.049
| 0.049
| 0.049
| 0.049
| 0.049
|-
| Pelvic inflammatory disease
| 0.169
| 0.169
| 0.169
| 0.169
| 0.169
|
| 0.169
| 0.169
| 0.169
| 0.169
| 0.169
|-
| Ectopic pregnancy
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Tubo-ovarian abscess
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|
| 0.000
| 0.549
| 0.549
| 0.549
| 0.000
|-
| Chronic pelvic pain
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|
| 0.122
| 0.122
| 0.122
| 0.122
| 0.122
|-
| Infertility
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Symptomatic urethritis
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|
| 0.067
| 0.067
| 0.067
| 0.067
| 0.067
|-
| Epididymitis
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|
| 0.167
| 0.167
| 0.167
| 0.167
| 0.167
|-
| Stricture
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|
| 0.151
| 0.151
| 0.151
| 0.151
| 0.151
|-
| HIV
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.123
| 0.123
| 0.136
| 0.136
| 0.136
|
| 0.123
| 0.123
| 0.136
| 0.136
| 0.136
|-
| AIDS
| 0.505
| 0.505
| 0.505
| 0.505
| 0.505
|
| 0.505
| 0.505
| 0.505
| 0.505
| 0.505
|-
| Diarrhoeal diseases -- Episodes
| 0.119
| 0.094
| 0.086
| 0.086
| 0.088
|
| 0.119
| 0.094
| 0.086
| 0.086
| 0.088
|-
| Pertussis
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.178
| 0.166
| 0.156
| 0.156
| 0.156
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Mental retardation
| 0.469
| 0.483
| 0.483
| 0.486
| 0.485
|
| 0.394
| 0.420
| 0.451
| 0.466
| 0.468
|-
| Poliomyelitis -- Lameness
| 0.369
| 0.369
| 0.369
| 0.369
| 0.369
|
| 0.369
| 0.369
| 0.369
| 0.369
| 0.369
|-
| Diphtheria
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.231
| 0.230
| 0.230
| 0.230
| 0.230
|
| 0.231
| 0.230
| 0.230
| 0.230
| 0.230
|-
| Neurological complications
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|-
| Myocarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|-
| Measles -- Episodes
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|-
| Tetanus -- Episodes
| 0.640
| 0.640
| 0.610
| 0.604
| 0.612
|
| 0.640
| 0.640
| 0.610
| 0.604
| 0.612
|-
| Bacterial meningitis, meningococcaemia
|
|
|
|
|
|
|
|
|
|
|
|-
| Streptococcus pneumoniae -- Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Haemophilus influenzae -- Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Neisseria meningitidis -- Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Meningococcaemia without meningitis --
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|
| 0.152
| 0.152
| 0.152
| 0.152
| 0.152
|-
| Deafness
| 0.233
| 0.227
| 0.216
| 0.215
| 0.213
|
| 0.175
| 0.169
| 0.168
| 0.168
| 0.168
|-
| Seizure disorder
| 0.099
| 0.150
| 0.150
| 0.150
| 0.150
|
| 0.041
| 0.065
| 0.065
| 0.065
| 0.065
|-
| Motor deficit
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|
| 0.334
| 0.334
| 0.334
| 0.337
| 0.390
|-
| Mental retardation
| 0.469
| 0.483
| 0.483
| 0.486
| 0.485
|
| 0.394
| 0.420
| 0.451
| 0.466
| 0.468
|-
| Hepatitis B and hepatitis C -- Episodes
| 0.170
| 0.181
| 0.209
| 0.212
| 0.212
|
| 0.170
| 0.181
| 0.209
| 0.212
| 0.212
|-
| Malaria
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|-
| Anaemia
| 0.012
| 0.012
| 0.012
| 0.013
| 0.012
|
| 0.012
| 0.012
| 0.012
| 0.013
| 0.012
|-
| Neurological sequelae
| 0.473
| 0.473
| 0.473
| 0.473
| 0.473
|
| 0.436
| 0.435
| 0.435
| 0.435
| 0.435
|-
| Trypanosomiasis -- Episodes
| 0.350
| 0.350
| 0.350
| 0.350
| 0.350
|
| 0.350
| 0.350
| 0.350
| 0.350
| 0.350
|-
| Chagas disease
|
|
|
|
|
|
|
|
|
|
|
|-
| Infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cardiomyopathy without congestive
|
|
|
|
|
|
|
|
|
|
|-
| heart failure
| 0.062
| 0.062
| 0.062
| 0.062
| 0.062
|
| 0.062
| 0.062
| 0.062
| 0.062
| 0.062
|-
| Cardiomyopathy with congestive
|
|
|
|
|
|
|
|
|
|
|-
| heart failure
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Megaviscera
| 0.240
| 0.240
| 0.240
| 0.240
| 0.240
|
| 0.240
| 0.240
| 0.240
| 0.240
| 0.240
|-
| Schistosomiasis -- Infection
| 0.005
| 0.005
| 0.006
| 0.006
| 0.006
|
| 0.005
| 0.005
| 0.006
| 0.006
| 0.006
|-
| Leishmaniasis
|
|
|
|
|
|
|
|
|
|
|
|-
| Visceral
| 0.243
| 0.243
| 0.243
| 0.243
| 0.243
|
| 0.243
| 0.243
| 0.243
| 0.243
| 0.243
|-
| Cutaneous
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|-
| Lymphatic filariasis
|
|
|
|
|
|
|
|
|
|
|
|-
| Hydrocele &gt;15 cm
| 0.066
| 0.070
| 0.075
| 0.075
| 0.075
|
| 0.066
| 0.070
| 0.075
| 0.075
| 0.075
|-
| Bancroftian lymphoedema
| 0.067
| 0.080
| 0.113
| 0.128
| 0.119
|
| 0.067
| 0.080
| 0.113
| 0.128
| 0.119
|-
| Brugian lymphoedema
| 0.064
| 0.080
| 0.113
| 0.128
| 0.119
|
| 0.064
| 0.080
| 0.113
| 0.128
| 0.119
|-
| Onchocerciasis
|
|
|
|
|
|
|
|
|
|
|
|-
| Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Itching
| 0.068
| 0.068
| 0.068
| 0.068
| 0.068
|
| 0.068
| 0.068
| 0.068
| 0.068
| 0.068
|-
| Low vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Leprosy
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Disabling leprosy
| 0.153
| 0.153
| 0.153
| 0.153
| 0.153
|
| 0.153
| 0.153
| 0.153
| 0.153
| 0.153
|-
| Dengue
|
|
|
|
|
|
|
|
|
|
|
|-
| Dengue haemorrhagic fever
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|
| 0.211
| 0.195
| 0.172
| 0.172
| 0.172
|-
| Japanese encephalitis
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|
| 0.616
| 0.616
| 0.613
| 0.613
| 0.613
|-
| Cognitive impairment
| 0.469
| 0.483
| 0.483
| 0.486
| 0.485
|
| 0.394
| 0.420
| 0.451
| 0.466
| 0.468
|-
| Neurological sequelae
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|
| 0.334
| 0.334
| 0.334
| 0.337
| 0.390
|-
| Trachoma
|
|
|
|
|
|
|
|
|
|
|
|-
| Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Low Vision
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|
| 0.223
| 0.245
| 0.245
| 0.245
| 0.245
|-
| Ascariasis
|
|
|
|
|
|
|
|
|
|
|
|-
| High intensity infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cotemporaneous cognitive deficit
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|-
| Cognitive impairment
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|-
| Intestinal obstruction
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Trichuriasis
|
|
|
|
|
|
|
|
|
|
|
|-
| High intensity infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cotemporaneous cognitive deficit
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|-
| Massive dysentery syndrome
| 0.138
| 0.116
| 0.114
| 0.114
| 0.129
|
| 0.138
| 0.116
| 0.114
| 0.114
| 0.129
|-
| Cognitive impairment
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Ancylostomiasis and necatoriasis
|
|
|
|
|
|
|
|
|
|
|
|-
| High intensity infection
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Anaemia
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Cognitive impairment
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Lower respiratory infections
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|
| 0.280
| 0.280
| 0.276
| 0.276
| 0.280
|-
| Chronic sequelae
| 0.099
| 0.099
| 0.099
| 0.099
| 0.099
|
| 0.099
| 0.099
| 0.099
| 0.099
| 0.099
|-
| Upper respiratory infections
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Pharyngitis
| 0.070
| 0.070
| 0.070
| 0.070
| 0.070
|
| 0.070
| 0.070
| 0.070
| 0.070
| 0.070
|-
| Otitis media
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|
| 0.023
| 0.023
| 0.023
| 0.023
| 0.023
|-
| Deafness
| 0.233
| 0.227
| 0.216
| 0.215
| 0.213
|
| 0.175
| 0.169
| 0.168
| 0.168
| 0.168
|-
| Maternal haemorrhage
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Sheehan syndrome
| 0.065
| 0.065
| 0.065
| 0.065
| 0.065
|
| 0.065
| 0.065
| 0.065
| 0.065
| 0.065
|-
| Severe anaemia
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|-
| Maternal sepsis
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Infertility
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|-
| Hypertensive disorders of pregnancy
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Neurological sequelae
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|
| 0.388
| 0.388
| 0.388
| 0.397
| 0.468
|-
| Obstructed labour
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Stress incontinence
| 0.025
| 0.025
| 0.025
| 0.025
| 0.033
|
| 0.025
| 0.025
| 0.025
| 0.025
| 0.033
|-
| Rectovaginal fistula
| 0.000
| 0.000
| 0.430
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.430
| 0.000
| 0.000
|-
| Abortion
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Infertility
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.180
| 0.000
| 0.000
|-
| Low birth weight -- All sequelae
| 0.291
| 0.291
| 0.291
| 0.291
| 0.291
|
| 0.256
| 0.256
| 0.256
| 0.256
| 0.256
|-
| Birth asphyxia and birth trauma --
|
|
|
|
|
|
|
|
|
|
|
|-
| All sequelae
| 0.381
| 0.381
| 0.381
| 0.381
| 0.381
|
| 0.334
| 0.334
| 0.334
| 0.334
| 0.334
|-
| Protein-energy malnutrition
|
|
|
|
|
|
|
|
|
|
|
|-
| Wasting
| 0.053
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.053
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Stunting
| 0.002
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.002
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Developmental disability
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Iodine deficiency
|
|
|
|
|
|
|
|
|
|
|
|-
| Goitre -- grade 0
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Goitre -- grade 1
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|-
| Goitre -- grade 2
| 0.025
| 0.025
| 0.025
| 0.025
| 0.025
|
| 0.025
| 0.025
| 0.025
| 0.025
| 0.025
|-
| Mild developmental disability
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|
| 0.006
| 0.006
| 0.006
| 0.006
| 0.006
|-
| Cretinoidism
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|-
| Cretinism
| 0.804
| 0.804
| 0.804
| 0.804
| 0.804
|
| 0.804
| 0.804
| 0.804
| 0.804
| 0.804
|-
| Vitamin A deficiency
|
|
|
|
|
|
|
|
|
|
|
|-
| Xerophthalmia
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Corneal scar
| 0.274
| 0.282
| 0.282
| 0.282
| 0.282
|
| 0.274
| 0.282
| 0.282
| 0.282
| 0.282
|-
| Iron-deficiency anaemia
|
|
|
|
|
|
|
|
|
|
|
|-
| Mild
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Moderate
| 0.011
| 0.011
| 0.011
| 0.012
| 0.012
|
| 0.011
| 0.011
| 0.011
| 0.012
| 0.012
|-
| Severe
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|
| 0.087
| 0.087
| 0.093
| 0.090
| 0.087
|-
| Very severe
| 0.241
| 0.244
| 0.255
| 0.252
| 0.252
|
| 0.241
| 0.244
| 0.255
| 0.252
| 0.252
|-
| Cognitive impairment
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|
| 0.024
| 0.024
| 0.024
| 0.024
| 0.024
|-
| Cancers -- Preterminal
|
|
|
|
|
|
|
|
|
|
|
|-
| Mouth and oropharynx
| 0.145
| 0.145
| 0.145
| 0.145
| 0.145
|
| 0.090
| 0.090
| 0.090
| 0.090
| 0.090
|-
| Oesophagus
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|-
| Stomach
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|-
| Colon and rectum
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|
| 0.217
| 0.217
| 0.217
| 0.217
| 0.217
|-
| Liver
| 0.239
| 0.239
| 0.239
| 0.239
| 0.239
|
| 0.239
| 0.239
| 0.239
| 0.239
| 0.239
|-
| Pancreas
| 0.301
| 0.301
| 0.301
| 0.301
| 0.301
|
| 0.237
| 0.237
| 0.237
| 0.237
| 0.237
|-
| Trachea, bronchus and lung
| 0.146
| 0.146
| 0.146
| 0.146
| 0.146
|
| 0.146
| 0.146
| 0.146
| 0.146
| 0.146
|-
| Melanoma and other skin
| 0.045
| 0.045
| 0.045
| 0.045
| 0.045
|
| 0.045
| 0.045
| 0.045
| 0.045
| 0.045
|-
| Breast
| 0.069
| 0.069
| 0.069
| 0.069
| 0.069
|
| 0.086
| 0.086
| 0.086
| 0.086
| 0.086
|-
| Cervix uteri
| 0.066
| 0.066
| 0.066
| 0.066
| 0.066
|
| 0.075
| 0.075
| 0.075
| 0.075
| 0.075
|-
| Corpus uteri
| 0.066
| 0.066
| 0.066
| 0.066
| 0.066
|
| 0.099
| 0.104
| 0.104
| 0.096
| 0.079
|-
| Ovary
| 0.081
| 0.081
| 0.081
| 0.081
| 0.081
|
| 0.097
| 0.097
| 0.097
| 0.084
| 0.059
|-
| Prostate
| 0.113
| 0.113
| 0.113
| 0.113
| 0.113
|
| 0.134
| 0.134
| 0.134
| 0.134
| 0.134
|-
| Bladder
| 0.085
| 0.085
| 0.085
| 0.085
| 0.085
|
| 0.087
| 0.087
| 0.087
| 0.087
| 0.085
|-
| Lymphomas and multiple myeloma
| 0.089
| 0.089
| 0.089
| 0.089
| 0.089
|
| 0.057
| 0.057
| 0.057
| 0.057
| 0.057
|-
| Leukaemia
| 0.098
| 0.098
| 0.108
| 0.112
| 0.112
|
| 0.083
| 0.083
| 0.093
| 0.097
| 0.097
|-
| Cancers -- Terminal
| 0.809
| 0.809
| 0.809
| 0.809
| 0.809
|
| 0.809
| 0.809
| 0.809
| 0.809
| 0.809
|-
| Diabetes mellitus
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.012
| 0.012
| 0.012
| 0.012
| 0.012
|
| 0.033
| 0.033
| 0.033
| 0.033
| 0.033
|-
| Diabetic foot
| 0.137
| 0.137
| 0.137
| 0.137
| 0.137
|
| 0.129
| 0.129
| 0.129
| 0.129
| 0.129
|-
| Neuropathy
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|-
| Retinopathy -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Amputation
| 0.155
| 0.155
| 0.155
| 0.155
| 0.155
|
| 0.068
| 0.068
| 0.068
| 0.068
| 0.068
|-
| Unipolar major depression -- episodes
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.302
| 0.302
| 0.302
| 0.302
| 0.302
|-
| Bipolar disorder -- Cases
| 0.583
| 0.583
| 0.583
| 0.583
| 0.583
|
| 0.383
| 0.383
| 0.383
| 0.383
| 0.383
|-
| Schizophrenia -- Cases
| 0.627
| 0.627
| 0.627
| 0.645
| 0.667
|
| 0.351
| 0.351
| 0.351
| 0.351
| 0.351
|-
| Epilepsy -- Cases
| 0.099
| 0.150
| 0.150
| 0.150
| 0.150
|
| 0.041
| 0.065
| 0.065
| 0.065
| 0.065
|-
| Alcohol use --
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Alcohol dependence syndrome
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Dementia -- Cases
| 0.627
| 0.627
| 0.627
| 0.645
| 0.667
|
| 0.627
| 0.627
| 0.627
| 0.645
| 0.667
|-
| Parkinson disease -- Cases
| 0.392
| 0.392
| 0.392
| 0.392
| 0.406
|
| 0.316
| 0.316
| 0.316
| 0.316
| 0.332
|-
| Multiple sclerosis -- Cases
| 0.410
| 0.410
| 0.410
| 0.420
| 0.437
|
| 0.410
| 0.410
| 0.410
| 0.420
| 0.437
|-
| Drug use --
|
|
|
|
|
|
|
|
|
|
|
|-
| Dysfunctional and harmful drug use
| 0.252
| 0.252
| 0.250
| 0.250
| 0.250
|
| 0.252
| 0.252
| 0.250
| 0.250
| 0.250
|-
| Post-traumatic stress disorder -- Cases
| 0.105
| 0.105
| 0.108
| 0.108
| 0.108
|
| 0.105
| 0.105
| 0.108
| 0.108
| 0.108
|-
| Obsessive-compulsive disorders --
|
|
|
|
|
|
|
|
|
|
|
|-
| Cases
| 0.129
| 0.129
| 0.129
| 0.129
| 0.129
|
| 0.080
| 0.080
| 0.080
| 0.080
| 0.080
|-
| Panic disorder -- Cases
| 0.173
| 0.173
| 0.173
| 0.173
| 0.173
|
| 0.091
| 0.091
| 0.091
| 0.091
| 0.091
|-
| Glaucoma -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|-
| Cataracts -- Blindness
| 0.600
| 0.600
| 0.600
| 0.600
| 0.600
|
| 0.493
| 0.491
| 0.488
| 0.488
| 0.488
|-
| Rheumatic heart disease --
|
|
|
|
|
|
|
|
|
|
|
|-
| Congestive heart failure
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Ischaemic heart disease
|
|
|
|
|
|
|
|
|
|
|
|-
| Acute myocardial infarction
| 0.491
| 0.491
| 0.491
| 0.491
| 0.491
|
| 0.395
| 0.395
| 0.395
| 0.395
| 0.395
|-
| Angina pectoris
| 0.227
| 0.227
| 0.227
| 0.227
| 0.227
|
| 0.095
| 0.095
| 0.095
| 0.095
| 0.095
|-
| Congestive heart failure
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Cerebrovascular disease --
|
|
|
|
|
|
|
|
|
|
|
|-
| First-ever stroke
| 0.262
| 0.262
| 0.262
| 0.268
| 0.301
|
| 0.224
| 0.224
| 0.224
| 0.224
| 0.258
|-
| Inflammatory heart diseases
|
|
|
|
|
|
|
|
|
|
|
|-
| Myocarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Pericarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Endocarditis
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| Cardiomyopathy
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.171
| 0.171
| 0.171
| 0.171
| 0.171
|-
| COPD -- Symptomatic cases
| 0.428
| 0.428
| 0.428
| 0.428
| 0.428
|
| 0.388
| 0.388
| 0.388
| 0.388
| 0.388
|-
| Asthma -- Cases
| 0.099
| 0.099
| 0.099
| 0.099
| 0.099
|
| 0.059
| 0.059
| 0.059
| 0.059
| 0.059
|-
| Peptic ulcer -- Cases
| 0.115
| 0.115
| 0.115
| 0.115
| 0.115
|
| 0.003
| 0.003
| 0.003
| 0.003
| 0.003
|-
| Cirrhosis of the liver --
|
|
|
|
|
|
|
|
|
|
|
|-
| Symptomatic cases
| 0.330
| 0.330
| 0.330
| 0.330
| 0.330
|
| 0.330
| 0.330
| 0.330
| 0.330
| 0.330
|-
| Appendicitis -- Episodes
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|
| 0.463
| 0.463
| 0.463
| 0.463
| 0.463
|-
| Nephritis and nephrosis
|
|
|
|
|
|
|
|
|
|
|
|-
| Acute glomerulonephritis
| 0.082
| 0.082
| 0.104
| 0.104
| 0.104
|
| 0.107
| 0.107
| 0.107
| 0.096
| 0.096
|-
| End-stage renal disease
| 0.082
| 0.082
| 0.104
| 0.104
| 0.104
|
| 0.107
| 0.107
| 0.107
| 0.096
| 0.096
|-
| Benign prostatic hypertrophy --
|
|
|
|
|
|
|
|
|
|
|
|-
| Symptomatic cases
| 0.038
| 0.038
| 0.038
| 0.038
| 0.038
|
| 0.038
| 0.038
| 0.038
| 0.038
| 0.038
|-
| Rheumatoid arthritis -- Cases
| 0.233
| 0.233
| 0.233
| 0.233
| 0.233
|
| 0.174
| 0.174
| 0.174
| 0.174
| 0.174
|-
| Osteoarthritis
|
|
|
|
|
|
|
|
|
|
|
|-
| Hip
| 0.156
| 0.156
| 0.156
| 0.156
| 0.156
|
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|-
| Knee
| 0.156
| 0.156
| 0.156
| 0.156
| 0.156
|
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|-
| Congenital anomalies
|
|
|
|
|
|
|
|
|
|
|
|-
| Abdominal wall defect -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Anencephaly -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Anorectal atresia -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cleft lip -- Cases
| 0.098
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.016
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Cleft palate -- Cases
| 0.231
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.015
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Oesophageal atresia -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Renal agenesis -- Cases
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.850
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Down syndrome -- Cases
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|-
| Congenital heart anomalies -- Cases
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|
| 0.323
| 0.323
| 0.323
| 0.323
| 0.323
|-
| Spina bifida -- Cases
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|
| 0.593
| 0.593
| 0.593
| 0.593
| 0.593
|-
| Dental caries -- Episodes
| 0.081
| 0.081
| 0.081
| 0.081
| 0.081
|
| 0.081
| 0.081
| 0.081
| 0.081
| 0.081
|-
| Periodontal disease -- Episodes
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|-
| Edentulism -- Cases
| 0.061
| 0.061
| 0.061
| 0.061
| 0.061
|
| 0.001
| 0.001
| 0.001
| 0.001
| 0.001
|-
| Drownings
|
|
|
|
|
|
|
|
|
|
|
|-
| Episodes
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|-
| Quadriplegia
| 0.005
| 0.005
| 0.005
| 0.005
| 0.005
|
| 0.005
| 0.005
| 0.005
| 0.005
| 0.005
|-
| Poisoning -- Episodes
| 0.611
| 0.611
| 0.607
| 0.607
| 0.607
|
| 0.611
| 0.611
| 0.607
| 0.607
| 0.607
|-
| Fractures
|
|
|
|
|
|
|
|
|
|
|
|-
| Skull -- Short term
| 0.431
| 0.431
| 0.431
| 0.431
| 0.431
|
| 0.431
| 0.431
| 0.431
| 0.431
| 0.431
|-
| Skull -- Long term
| 0.411
| 0.411
| 0.411
| 0.410
| 0.395
|
| 0.350
| 0.350
| 0.350
| 0.350
| 0.404
|-
| Face bones
| 0.223
| 0.223
| 0.223
| 0.223
| 0.223
|
| 0.223
| 0.223
| 0.223
| 0.223
| 0.223
|-
| Vertebral column
| 0.266
| 0.266
| 0.266
| 0.266
| 0.266
|
| 0.266
| 0.266
| 0.266
| 0.266
| 0.266
|-
| Injured spinal cord
| 0.725
| 0.725
| 0.725
| 0.725
| 0.725
|
| 0.725
| 0.725
| 0.725
| 0.725
| 0.725
|-
| Fractures
|
|
|
|
|
|
|
|
|
|
|
|-
| Rib or sternum
| 0.199
| 0.199
| 0.199
| 0.199
| 0.199
|
| 0.199
| 0.199
| 0.199
| 0.199
| 0.199
|-
| Pelvis
| 0.247
| 0.247
| 0.247
| 0.247
| 0.247
|
| 0.247
| 0.247
| 0.247
| 0.247
| 0.247
|-
| Clavicle, scapula, or humerus
| 0.153
| 0.153
| 0.137
| 0.137
| 0.137
|
| 0.153
| 0.153
| 0.137
| 0.137
| 0.137
|-
| Radius or ulna
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|
| 0.180
| 0.180
| 0.180
| 0.180
| 0.180
|-
| Hand bones
| 0.100
| 0.100
| 0.100
| 0.100
| 0.100
|
| 0.100
| 0.100
| 0.100
| 0.100
| 0.100
|-
| Femur -- Short term
| 0.372
| 0.372
| 0.372
| 0.372
| 0.372
|
| 0.372
| 0.372
| 0.372
| 0.372
| 0.372
|-
| Femur -- Long term
| 0.272
| 0.272
| 0.272
| 0.272
| 0.272
|
| 0.272
| 0.272
| 0.272
| 0.272
| 0.272
|-
| Patella, tibia, or fibula
| 0.271
| 0.271
| 0.271
| 0.271
| 0.271
|
| 0.271
| 0.271
| 0.271
| 0.271
| 0.271
|-
| Ankle
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|
| 0.196
| 0.196
| 0.196
| 0.196
| 0.196
|-
| Foot bones
| 0.077
| 0.077
| 0.077
| 0.077
| 0.077
|
| 0.077
| 0.077
| 0.077
| 0.077
| 0.077
|-
| Dislocated shoulder, elbow, or hip
| 0.074
| 0.074
| 0.074
| 0.074
| 0.074
|
| 0.074
| 0.074
| 0.074
| 0.074
| 0.074
|-
| Sprains
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|-
| Intracranial injury
|
|
|
|
|
|
|
|
|
|
|
|-
| Short term
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|-
| Long term
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|
| 0.359
| 0.359
| 0.359
| 0.359
| 0.359
|-
| Internal injuries
| 0.000
| 0.000
| 0.000
| 0.000
| 0.000
|
| 0.208
| 0.208
| 0.208
| 0.208
| 0.208
|-
| Open wound
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|
| 0.108
| 0.108
| 0.108
| 0.108
| 0.108
|-
| Injury to eyes
| 0.354
| 0.354
| 0.354
| 0.354
| 0.354
|
| 0.301
| 0.300
| 0.299
| 0.299
| 0.299
|-
| Amputations
|
|
|
|
|
|
|
|
|
|
|
|-
| Thumb
| 0.165
| 0.165
| 0.165
| 0.165
| 0.165
|
| 0.165
| 0.165
| 0.165
| 0.165
| 0.165
|-
| Finger
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|-
| Arm
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|
| 0.102
| 0.102
| 0.102
| 0.102
| 0.102
|-
| Toe
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|-
| Foot
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|-
| Leg
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|
| 0.300
| 0.300
| 0.300
| 0.300
| 0.300
|-
| Crushing
| 0.218
| 0.218
| 0.218
| 0.218
| 0.218
|
| 0.218
| 0.218
| 0.218
| 0.218
| 0.218
|-
| Burns
|
|
|
|
|
|
|
|
|
|
|
|-
| &lt;20% -- Short term
| 0.186
| 0.186
| 0.186
| 0.186
| 0.186
|
| 0.158
| 0.158
| 0.158
| 0.158
| 0.158
|-
| &lt;20% -- Long term
| 0.041
| 0.041
| 0.041
| 0.041
| 0.041
|
| 0.011
| 0.011
| 0.011
| 0.011
| 0.011
|-
| &gt;20% and &lt;60% -- Short term
| 0.469
| 0.469
| 0.469
| 0.469
| 0.469
|
| 0.441
| 0.441
| 0.441
| 0.441
| 0.441
|-
| &gt;20% and &lt;60% -- Long term
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|-
| &gt;60% -- Short term
| 0.469
| 0.469
| 0.469
| 0.469
| 0.469
|
| 0.441
| 0.441
| 0.441
| 0.441
| 0.441
|-
| &gt;60% -- Long term
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|
| 0.255
| 0.255
| 0.255
| 0.255
| 0.255
|-
| Injured nerves
| 0.078
| 0.078
| 0.078
| 0.078
| 0.078
|
| 0.064
| 0.064
| 0.064
| 0.064
| 0.064
|}
 
Figure 1. An illustrative graph of the severity weights for different cancers
[[Image:Cancer DALY01.jpg]]
 
== See also ==


* [[Global Burden of Disease Study]]
* [[Disability-adjusted life years]]
* [[:en:Disability-adjusted life year|Disability-adjusted life year]] in Wikipedia
*WHO report describing DALYs and presents disability weights: Murray CJL, Lopez AD, eds. 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, Harvard School of Public Health on behalf of the World Health Organization and the World Bank.  
*WHO report describing DALYs and presents disability weights: Murray CJL, Lopez AD, eds. 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, Harvard School of Public Health on behalf of the World Health Organization and the World Bank.  
*An update of the disability weights [http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf]  
*An update of the disability weights [http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf]  
*Data by regions (European), for example YLD (years of life lived with the disease) [http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/]  
*Data by regions (European), for example YLD (years of life lived with the disease) [http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/]  
*Dutch disability weights [http://www.rivm.nl/vtv/object_document/o1676n18840.html] (Available only in Dutch)  
*Dutch disability weights [http://www.rivm.nl/vtv/object_document/o1676n18840.html] (Available only in Dutch)  
*Severity weights for noise outcomes<br>
*[[Severity weights for noise outcomes]]


==References==
==References==


<references/>
<references/>
[[Category:THL publications 2010]]
[[Category:THL publications 2010]]

Latest revision as of 10:08, 26 August 2013



Disability weights describe the weights that are given to different diseases in the calculation of disability-adjusted life years (DALY).

Question

What are disability weights for different disases, and how should they be used in calculating burden of disease?

Answer

This code can be used on this page to calculate YLD (years of life under disease). The code can also be copied to another page in Opasnet. It runs on R, so it is also possible to copy and use it outside the Opasnet workspace.

How many cases of disease are there? (#):

What is the duration of disease? (years):

+ Show code

NOTE! Old official WHO disability weights were used in a previous version of this page. The current version uses disability weights from Salomon (Salomon et al., Lancet 2012-2013

[1]).

D↷

Rationale

Data

Disability weights are obtained by posing two different Person Trade-Off (PTO) questions to expert panels

  • Question 1 compares life extensions for disabled and healthy people
  • Question 2 compares cures for illness with extension of life

Ideally, these values should be derived from empirical data among representative populations. Combining the answers to these questions results in an average disability weight. Usually, these weights are presented as a fixed parameter, without a confidence interval or other type of distribution.

Arguments defending this approach include:

  • DALY weights are an intrinsically subjective value for which no "true estimate" exists. They should be treated as a normative value, which does not need further uncertainty intervals.
  • Uncertainty in very small DALY weights (for less severe effects) affects overall outcomes of DALY calculations much more than uncertainty in large disability weights. This is a "flaw" of the method: if health would be defined as 1 and death as 0 (as is being done with QALYs), the more severe outcomes would have more overall uncertainty. The uncertainty is greatest for the smallest disability weights and narrows as more severe weights are attained (figure 5.16

[2] ).This provides a skewed image. In order to avoid this, distributions should not be used. Another solution might be to normalize the weights. D↷

Arguments opposing this approach include:

  • Estimates of DALY weights differ between experts, so this variation should be presented in the overall distribution of these weights.

Including uncertainty intervals of disability weights will probably not affect the ranking of overall disease burden estimates very significantly (WHO GBD study). However, it will affect the confidence interval of individual estimates.



List of data files or sources:

Disability weights

Comment: ICD (ICD-10) codes should be added for indexing/OH 19 May 2009

The previous version of disability weights is archived. The data was from [2] (WHO → GBD → Tools → National tools → NATIONAL BURDEN OF DISEASE SUPPLEMENTARY FILES → Disability weights [xls 313kb]).

Disability weights based on IHME (Salomon et al., Lancet 13 Dec, 2012):

Disability weights: Difference between revisions(fraction)
ObsDiagnosisWeight
1Infectious disease: acute episode, mild0.005 (0.002-0.011)
2Infectious disease: acute episode, moderate0.053 (0.033-0.081)
3Infectious disease: acute episode, severe0.210 (0.139-0.298)
4Infectious disease: post-acute consequences (fatigue, emotional lability, insomnia)0.254 (0.170-0.355)
5Diarrhoea: mild0.061 (0.036-0.093)
6Diarrhoea: moderate0.202 (0.133-0.299)
7Diarrhoea: severe0.281 (0.184-0.399)
8Epididymo-orchitis0.097 (0.063-0.137)
9Herpes zoster0.061 (0.039-0.094)
10HIV: symptomatic, pre-AIDS0.221 (0.146-0.310)
11HIV/AIDS: receiving antiretroviral treatment0.053 (0.034-0.079)
12AIDS: not receiving antiretroviral treatment0.547 (0.382-0.715)
13Intestinal nematode infections: symptomatic0.030 (0.016-0.048)
14Lymphatic filariasis: symptomatic0.110 (0.073-0.157)
15Ear pain0.018 (0.009-0.031)
16Tuberculosis: without HIV infection0.331 (0.222- 0.450)
17Tuberculosis: with HIV infection0.399 (0.267-0.547)
18Cancer: diagnosis and primary therapy0.294 (0.199-0.411)
19Cancer: metastatic0.484 (0.330-0.643)
20Mastectomy0.038 (0.022-0.059)
21Stoma0.086 (0.055-0.131)
22Terminal phase: with medication (for cancers, end-stage kidney or liver disease)0.508 (0.348-0.670)
23Terminal phase: without medication (for cancers, end-stage kidney or liver disease)0.519 (0.356-0.683)
24Acute myocardial infarction: days 1-20.422 (0.284-0.566)
25Acute myocardial infarction: days 3-280.056 (0.035-0.082)
26Angina pectoris: mild0.037 (0.022-0.058)
27Angina pectoris: moderate0.066 (0.043-0.095)
28Angina pectoris: severe0.167 (0.109-0.234)
29Cardiac conduction disorders and cardiac dysrhythmias0.145 (0.097-0.205)
30Claudication0.016 (0.008-0.028)
31Heart failure: mild0.037 (0.021-0.058)
32Heart failure: moderate0.070 (0.044-0.102)
33Heart failure: severe0.186 (0.128-0.261)
34Stroke: long-term consequences, mild0.021 (0.011-0.037)
35Stroke: long-term consequences, moderate0.076 (0.050-0.110)
36Stroke: long-term consequences, moderate plus cognition problems0.312 (0.211-0.433)
37Stroke: long-term consequences, severe0.539 (0.363-0.705)
38Stroke: long-term consequences, severe plus cognition problems0.567 (0.394-0.738)
39Diabetic foot0.023 (0.012-0.039)
40Diabetic neuropathy0.099 (0.066-0.145)
41Chronic kidney disease (stage IV)0.105 (0.069-0.154)
42End-stage renal disease: with kidney transplant0.027 (0.015-0.043)
43End-stage renal disease: on dialysis0.573 (0.397-0.749)
44Decompensated cirrhosis of the liver0.194 (0.127-0.273)
45Gastric bleeding0.323 (0.214-0.461)
46Crohn's disease or ulcerative colitis0.225 (0.152-0.314)
47Benign prostatic hypertrophy: symptomatic0.070 (0.046-0.102)
48Urinary incontinence0.142 (0.094-0.204)
49Impotence0.019 (0.010-0.034)
50Infertility: primary0.011 (0.005-0.021)
51Infertility: secondary0.006 (0.002-0.013)
52Asthma: controlled0.009 (0.004-0.018)
53Asthma: partially controlled0.027 (0.015-0.045)
54Asthma: uncontrolled0.132 (0.087-0.190)
55COPD and other chronic respiratory diseases: mild0.015 (0.007-0.028)
56COPD and other chronic respiratory diseases: moderate0.192 (0.129-0.271)
57COPD and other chronic respiratory diseases: severe0.383 (0.259-0.528)
58Dementia: mild0.082 (0.055-0.117)
59Dementia: moderate0.346 (0.233-0.475)
60Dementia: severe0.438 (0.299-0.584)
61Headache: migraine0.433 (0.287-0.593)
62Headache: tension-type0.040 (0.025-0.062)
63Multiple sclerosis: mild0.198 (0.137-0.278)
64Multiple sclerosis: moderate0.445 (0.303-0.593)
65Multiple sclerosis: severe0.707 (0.522-0.857)
66Epilepsy: treated, seizure free0.072 (0.047-0.106)
67Epilepsy: treated, with recent seizures0.319 (0.211-0.445)
68Epilepsy: untreated0.420 (0.279-0.572)
69Epilepsy: severe0.657 (0.464-0.827)
70Parkinson's disease: mild0.011 (0.005-0.021)
71Parkinson's disease: moderate0.263 (0.179-0.360)
72Parkinson's disease: severe0.549 (0.383-0.711)
73Alcohol use disorder: mild0.259 (0.176-0.359)
74Alcohol use disorder: moderate0.388 (0.262-0.529)
75Alcohol use disorder: severe0.549 (0.384-0.708)
76Fetal alcohol syndrome: mild0.017 (0.008-0.032)
77Fetal alcohol syndrome: moderate0.057 (0.036-0.087)
78Fetal alcohol syndrome: severe0.177 (0.117-0.255)
79Cannabis dependence0.329 (0.223-0.455)
80Amphetamine dependence0.353 (0.215-0.525)
81Cocaine dependence0.376 (0.235-0.553)
82Heroin and other opioid dependence0.641 (0.459-0.803)
83Anxiety disorders: mild0.030 (0.017-0.048)
84Anxiety disorders: moderate0.149 (0.101-0.210)
85Anxiety disorders: severe0.523 (0.365-0.684)
86Major depressive disorder: mild episode0.159 (0.107-0.223)
87Major depressive disorder: moderate episode0.406 (0.276-0.551)
88Major depressive disorder: severe episode0.655 (0.469-0.816)
89Bipolar disorder: manic episode0.480 (0.323-0.642)
90Bipolar disorder: residual state0.035 (0.021-0.055)
91Schizophrenia: acute state0.756 (0.571-0.894)
92Schizophrenia: residual state0.576 (0.399-0.756)
93Anorexia nervosa0.223 (0.151-0.313)
94Bulimia nervosa0.223 (0.150-0.310)
95Attention-deficit hyperactivity disorder0.049 (0.031-0.074)
96Conduct disorder0.236 (0.154-0.337)
97Asperger's syndrome0.110 (0.073-0.157)
98Autism0.259 (0.177-0.362)
99Intellectual disability: mild0.031 (0.018-0.049)
100Intellectual disability: moderate0.080 (0.053-0.114)
101Intellectual disability: severe0.126 (0.085-0.176)
102Intellectual disability: profound0.157 (0.107-0.221)
103Hearing loss: mild0.005 (0.002-0.012)
104Hearing loss: moderate0.023 (0.013-0.038)
105Hearing loss: severe0.032 (0.018-0.051)
106Hearing loss: profound0.031 (0.018-0.049)
107Hearing loss: complete0.033 (0.020-0.052)
108Hearing loss: mild, with ringing0.038 (0.024-0.058)
109Hearing loss: moderate, with ringing0.058 (0.037-0.085)
110Hearing loss: severe, with ringing0.065 (0.041-0.094)
111Hearing loss: profound, with ringing0.088 (0.058-0.127)
112Hearing loss: complete, with ringing0.092 (0.061-0.134)
113Distance vision: mild impairment0.004 (0.001-0.010)
114Distance vision: moderate impairment0.033 (0.020-0.052)
115Distance vision: severe impairment0.191 (0.129-0.269)
116Distance vision blindness0.195 (0.132-0.272)
117Near vision impairment0.013 (0.006-0.024)
118Low back pain: acute, without leg pain0.269 (0.184-0.373)
119Low back pain: acute, with leg pain0.322 (0.219-0.447)
120Low back pain: chronic, without leg pain0.366 (0.248-0.499)
121Low back pain: chronic, with leg pain0.374 (0.252-0.506)
122Neck pain: acute, mild0.040 (0.023-0.064)
123Neck pain: acute, severe0.221 (0.150-0.305)
124Neck pain: chronic, mild0.101 (0.067-0.149)
125Neck pain: chronic, severe0.286 (0.197-0.398)
126Musculoskeletal problems: legs, mild0.023 (0.013-0.039)
127Musculoskeletal problems: legs, moderate0.079 (0.053-0.115)
128Musculoskeletal problems: legs, severe0.171 (0.117-0.240)
129Musculoskeletal problems: arms, mild0.024 (0.014-0.041)
130Musculoskeletal problems: arms, moderate0.114 (0.077-0.159)
131Musculoskeletal problems: generalised, moderate0.292 (0.197-0.410)
132Musculoskeletal problems: generalised, severe0.606 (0.421-0.771)
133Gout: acute0.293 (0.198-0.404)
134Amputation of finger(s), excluding thumb: long term, with treatment0.030 (0.018-0.048)
135Amputation of thumb: long term0.013 (0.006-0.025)
136Amputation of one arm: long term, with or without treatment0.130 (0.088-0.185)
137Amputation of both arms: long term, with treatment0.044 (0.028-0.067)
138Amputation of both arms: long term, without treatment0.359 (0.242-0.497)
139Amputation of toe0.008 (0.003-0.017)
140Amputation of one leg: long term, withtreatment0.021 (0.011-0.035)
141Amputation of one leg: long term, without treatment0.164 (0.111-0.229)
142Amputation of both legs: long term, with treatment0.051 (0.032-0.076)
143Amputation of both legs: long term, without treatment0.494 (0.341-0.654)
144Burns of <20% total surface area without lower airway burns: short term, with or without treatment0.096 (0.062-0.140)
145Burns of <20% total surface area or <10% total surface area if head or neck, or hands or wrist involved: long term, with or without treatment0.018 (0.010-0.032)
146Burns of ≥20% total surface area: short term, with or without treatment0.333 (0.220-0.472)
147Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, with treatment0.127 (0.086-0.183)
148Burns of ≥20% total surface area or ≥10% total surface area if head or neck, or hands or wrist involved: long term, without treatment0.438 (0.298-0.588)
149Lower airway burns: with or without treatment0.373 (0.248-0.521)
150Crush injury: short or long term, with or without treatment0.145 (0.093-0.211)
151Dislocation of hip: long term, with or without treatment0.017 (0.008-0.030)
152Dislocation of knee: long term, with or without treatment0.129 (0.087-0.178)
153Dislocation of shoulder: long term, with or without treatment0.080 (0.053-0.116)
154Other injuries of muscle and tendon (includes sprains, strains, and dislocations other than shoulder, knee, or hip)0.009 (0.004-0.018)
155Drowning and non-fatal submersion: short or long term, with or without treatment0.288 (0.191-0.403)
156Fracture of clavicle, scapula, or humerus: short or long term, with or without treatment0.053 (0.033-0.080)
157Fracture of face bone: short or long term, with or without treatment0.173 (0.111- 0.257)
158Fracture of foot bones: short term, with or without treatment0.033 (0.019-0.053)
159Fracture of foot bones: long term, without treatment0.033 (0.019-0.052)
160Fracture of hand: short term, with or without treatment0.025 (0.013-0.043)
161Fracture of hand: long term, without treatment0.016 (0.008-0.028)
162Fracture of neck of femur: short term, with or without treatment0.308 (0.205-0.439)
163Fracture of neck of femur: long term, with treatment0.072 (0.047-0.105)
164Fracture of neck of femur: long term, without treatment0.388 (0.261-0.532)
165Fracture other than neck of femur: short term, with or without treatment0.192 (0.121-0.280)
166Fracture other than neck of femur: long term, without treatment0.053 (0.035-0.079)
167Fracture of patella, tibia or fibula, or ankle: short term, with or without treatment0.087 (0.055-0.127)
168Fracture of patella, tibia or fibula, or ankle: long term, with or without treatment0.070 (0.047-0.102)
169Fracture of pelvis: short term0.390 (0.257-0.545)
170Fracture of pelvis: long term0.194 (0.132-0.272)
171Fracture of radius or ulna: short term, with or without treatment0.065 (0.040-0.101)
172Fracture of radius or ulna: long term, without treatment0.050 (0.032-0.075)
173Fracture of skull: short or long term, with or without treatment0.073 (0.046-0.109)
174Fracture of sternum or fracture of one or two ribs: short term, with or without treatment0.150 (0.098-0.215)
175Fracture of vertebral column: short or long term, with or without treatment0.132 (0.085-0.195)
176Fractures: treated, long term0.003 (0.001-0.008)
177Injured nerves: short term0.065 (0.040-0.096)
178Injured nerves: long term0.136 (0.092-0.189)
179Injury to eyes: short term0.079 (0.050-0.118)
180Severe traumatic brain injury: short term, with or without treatment0.235 (0.156-0.331)
181Traumatic brain injury: long-term consequences, minor, with or without treatment0.106 (0.072-0.147)
182Traumatic brain injury: long-term consequences, moderate, with or without treatment0.224 (0.153-0.314)
183Traumatic brain injury: long-term consequences, severe, with or without treatment0.625 (0.444-0.789)
184Open wound: short term, with or without treatment0.005 (0.002-0.013)
185Poisoning: short term, with or without treatment0.171 (0.116-0.239)
186Severe chest injury: long term, with or without treatment0.056 (0.036-0.082)
187Severe chest injury: short term, with or without treatment0.352 (0.229-0.484)
188Spinal cord lesion below neck: treated0.047 (0.029-0.072)
189Spinal cord lesion below neck: untreated0.440 (0.290-0.588)
190Spinal cord lesion at neck: treated0.369 (0.243-0.513)
191Spinal cord lesion at neck: untreated0.673 (0.475-0.837)
192Abdominopelvic problem: mild0.012 (0.005-0.023)
193Abdominopelvic problem: moderate0.123 (0.083-0.176)
194Abdominopelvic problem: severe0.326 (0.219-0.451)
195Anaemia: mild0.005 (0.002-0.011)
196Anaemia: moderate0.058 (0.038-0.086)
197Anaemia: severe0.164 (0.112-0.228)
198Periodontitis0.008 (0.003-0.017)
199Dental caries: symptomatic0.012 (0.005-0.023)
200Severe tooth loss0.072 (0.048-0.103)
201Disfigurement: level 10.013 (0.006-0.025)
202Disfigurement: level 20.072 (0.048-0.103)
203Disfigurement: level 30.398 (0.271-0.543)
204Disfigurement: level 1 with itch or pain0.029 (0.016-0.048)
205Disfigurement: level 2, with itch or pain0.187 (0.125-0.264)
206Disfigurement: level 3, with itch or pain0.562 (0.394-0.725)
207Generic uncomplicated disease: worry and daily medication0.031 (0.017-0.050)
208Generic uncomplicated disease: anxiety about diagnosis0.054 (0.033-0.082)
209Iodine-deficiency goitre0.200 (0.134-0.283)
210Kwashiorkor0.055 (0.033-0.085)
211Severe wasting0.127 (0.081-0.183)
212Speech problems0.054 (0.034-0.081)
213Motor impairment: mild0.012 (0.005-0.022)
214Motor impairment: moderate0.076 (0.050-0.109)
215Motor impairment: severe0.377 (0.251-0.518)
216Motor plus cognitive impairments: mild0.054 (0.033-0.084)
217Motor plus cognitive impairments: moderate0.221 (0.141-0.314)
218Motor plus cognitive impairments: severe0.425 (0.286-0.587)
219Rectovaginal fistula0.492 (0.330-0.660)
220Vesicovaginal fistula0.338 (0.228-0.467)

See also

  • Global Burden of Disease Study
  • Disability-adjusted life years
  • Disability-adjusted life year in Wikipedia
  • WHO report describing DALYs and presents disability weights: Murray CJL, Lopez AD, eds. 1996. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, Harvard School of Public Health on behalf of the World Health Organization and the World Bank.
  • An update of the disability weights [3]
  • Data by regions (European), for example YLD (years of life lived with the disease) [4]
  • Dutch disability weights [5] (Available only in Dutch)
  • Severity weights for noise outcomes

References

  1. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2013 Dec 15;380(9859):2129-43. doi:10.1016/S0140-6736(12)61680-8 .
  2. Colin D. Mathers, Joshua A. Salomon, Majid Ezzati, Stephen Begg, Stephen Vander Hoorn, and Alan D. Lopez, "Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates." 2006. Global Burden of Disease and Risk Factors,ed. , 399-426. New York: Oxford University Press. DOI: 10.1596/978-0-8213-6262-4/Chpt-5.